GN
Gregory Norden
Director

Gregory Norden insider trades: Royalty Pharma (RPRX) stock buys and sales

Director, Royalty Pharma Last trade May 14, 2026 85 Form 4 filings
$161K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2011
8
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Gregory reports to the SEC

and 2 more companies

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 14, 2026RPRX↓ Sell$161K
Aug 11, 2025RPRX↓ Sell$1.2M
Mar 7, 2023NSTG↑ Buy$123K
Nov 5, 2021ZTS↓ Sell$972K
Dec 7, 2020NSTG↓ Sell$607K
Aug 13, 2020NSTG↓ Sell$388K
Feb 6, 2013ZTS↑ Buy$78K
Mar 18, 2011HGSI↑ Buy$68K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other RPRX insiders

Open-market trades in the last 12 months

About Gregory Norden's insider trades

Gregory Norden is a director at Royalty Pharma (RPRX). Since Mar 18, 2011, Gregory has reported 3 open-market purchases worth $269K and 5 sales worth $3.3M on SEC Form 4. In the last 12 months: 1 sale ($161K).

Their filings also include grants and awards (53 filings), option exercises (18 filings), other transactions (13 filings), gifts (5 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RPRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.